Stockreport

MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements

MiNK Therapeutics, Inc.  (INKT) 
PDF NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, a [Read more]